Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/52076
FREQUENCY OF CXCR3+ CD8+ T-LMPHOCYTE SUBSETS IN PERIPHERAL BLOOD IS ASSOCIATED WITH THE RISK OF PRADOXICAL TUBERCULOSIS-ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME DEVELOPMENT IN ADVANCED HIV DISEASE
Author
Tibúrcio, Rafael
Narendran, opalan
Duarte, Beatriz Barreto
Queiroz, Artur T. L.
Pereira, Mariana Araújo
Anbalagan, Selvaraj
Nayak, Kaustuv
Ravichandran, Narayanan
Subramani, Rajasekaran
Antonelli, Lis R. V.
Satagopan, Kumar
Anbalagan, Komathi
Porter, Brian O.
Sher, Alan
Swaminathan, Soumya
Sereti, Irini
Andrade, Bruno B.
Narendran, opalan
Duarte, Beatriz Barreto
Queiroz, Artur T. L.
Pereira, Mariana Araújo
Anbalagan, Selvaraj
Nayak, Kaustuv
Ravichandran, Narayanan
Subramani, Rajasekaran
Antonelli, Lis R. V.
Satagopan, Kumar
Anbalagan, Komathi
Porter, Brian O.
Sher, Alan
Swaminathan, Soumya
Sereti, Irini
Andrade, Bruno B.
Affilliation
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores, Salvador, BA, Brasil / Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores, Salvador, BA, Brasil / Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Universidade Salvador. Curso de Medicina. Salvador, BA, Brasil / Universidade Federal do Rio de Janeiro. Programa de Pós-graduação em Clínica Médica. Rio de Janeiro, RJ, Brasil.
Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para a Saúde. Salvador, BA, Brasil.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores, Salvador, BA, Brasil / Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia. / ICGEB-Emory Vaccine Centre. International Centre for Genetic Engineering and Biotechnology. New Delhi, India,
Government Hospital of Thoracic Medicine. Chennai, Índia.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
Fundação Oswaldo Cruz. Instituto René Rachou. Laboratório de Biologia e Imunologia de Doenças Infecciosas e Parasitarias. Belo Horizonte, MG, Brasil.
Government Hospital of Thoracic Medicine. Chennai, Índia.
Government Hospital of Thoracic Medicine. Chennai, Índia.
HIV Pathogenesis Section. Laboratory of Immunoregulation. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, MD, United States.
Immunobiology Section. Laboratory of Parasitic Diseases. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, MD, United States.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
HIV Pathogenesis Section. Laboratory of Immunoregulation. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, MD, United States.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores, Salvador, BA, Brasil / Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil / Universidade Salvador. Curso de Medicina. Salvador, BA, Brasil / Universidade Federal do Rio de Janeiro. Programa de Pós-graduação em Clínica Médica. Rio de Janeiro, RJ, Brasil / Wellcome Trust Centre for Infectious Disease Research in Africa. Institute of Infectious Disease and Molecular Medicine. University of Cape Town. Cape Town, South Africa / Escola Bahiana de Medicina e Saúde Pública. Curso de Medicina. Salvador, BA, Brasil / Division of Infectious Diseases. Department of Medicine. Vanderbilt University School of Medicine. Nashville, TN, United States.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores, Salvador, BA, Brasil / Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Universidade Salvador. Curso de Medicina. Salvador, BA, Brasil / Universidade Federal do Rio de Janeiro. Programa de Pós-graduação em Clínica Médica. Rio de Janeiro, RJ, Brasil.
Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para a Saúde. Salvador, BA, Brasil.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores, Salvador, BA, Brasil / Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia. / ICGEB-Emory Vaccine Centre. International Centre for Genetic Engineering and Biotechnology. New Delhi, India,
Government Hospital of Thoracic Medicine. Chennai, Índia.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
Fundação Oswaldo Cruz. Instituto René Rachou. Laboratório de Biologia e Imunologia de Doenças Infecciosas e Parasitarias. Belo Horizonte, MG, Brasil.
Government Hospital of Thoracic Medicine. Chennai, Índia.
Government Hospital of Thoracic Medicine. Chennai, Índia.
HIV Pathogenesis Section. Laboratory of Immunoregulation. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, MD, United States.
Immunobiology Section. Laboratory of Parasitic Diseases. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, MD, United States.
Department of Clinical Research. National Institute for Research in Tuberculosis. Chennai, Índia.
HIV Pathogenesis Section. Laboratory of Immunoregulation. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, MD, United States.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores, Salvador, BA, Brasil / Rede de Organizações Multinacionais Patrocinando Iniciativa de Pesquisa Translacional e Epidemiológica, Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil / Universidade Salvador. Curso de Medicina. Salvador, BA, Brasil / Universidade Federal do Rio de Janeiro. Programa de Pós-graduação em Clínica Médica. Rio de Janeiro, RJ, Brasil / Wellcome Trust Centre for Infectious Disease Research in Africa. Institute of Infectious Disease and Molecular Medicine. University of Cape Town. Cape Town, South Africa / Escola Bahiana de Medicina e Saúde Pública. Curso de Medicina. Salvador, BA, Brasil / Division of Infectious Diseases. Department of Medicine. Vanderbilt University School of Medicine. Nashville, TN, United States.
Abstract
Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is a clinical aggravation of TB symptoms observed among a fraction of HIV coinfected patients shortly after the start of antiretroviral therapy (ART). Of note, TB-IRIS is characterized by exacerbated inflammation and tissue damage that occurs in response to the elevated production of CD4+ T cell-derived IFN-γ. Nevertheless, the possible participation of CD8+ T cells in TB-IRIS development remains unclear. ethods: We performed a comprehensive assessment of the composition of CD8+ T cell memory subsets and their association with circulating inflammation-related molecules in TB-HIV coinfected patients initiating ART. Results: We found that TB-IRIS individuals display higher frequencies of Antigen-experienced CD8+ T cells during the onset of IRIS and that the levels of these cells positively correlate with baseline mycobacterial smear grade. TB-IRIS individuals exhibited higher frequencies of effector memory and lower percentages of naïve CD8+ T cells than their Non-IRIS counterparts. In both TB-IRIS and Non-IRIS patients, ART commencement was associated with fewer significant correlations among memory CD8+ T cells and cells from other immune compartments. Networks analysis revealed distinct patterns of correlation between each memory subset with inflammatory cytokines suggesting different dynamics of CD8+ T cell memory subsets reconstitution. TB-IRIS patients displayed lower levels of memory cells positive for CXCR3 (a chemokine receptor that plays a role in trafficking activated CD8+ T cells to the tissues) than Non-IRIS individuals before and after ART. Furthermore, we found that CXCR3+ naïve CD8+ T cells were inversely associated with the risk of TB-IRIS development. On the other hand, we noticed that the frequencies of CXCR3+ effector CD8+ T cells were positively associated with the probability of TB-IRIS development. Conclusion: Our data suggest that TB-IRIS individuals display a distinct profile of memory CD8+ T cell subsets reconstitution after ART initiation. Moreover, our data point to a differential association between the frequencies of CXCR3+ CD8+ T cells and the risk of TB-IRIS development. Collectively, our findings lend insights into the potential role of memory CD8+ T cells in TB-IRIS pathophysiology.
Share